Filtered By:
Drug: Botox
This page shows you your search results in order of relevance. This is page number 9.
Order by Relevance | Date
Total 134 results found since Jan 2013.
Botulinum Toxin Use for Modulating Neuroimmune Cutaneous Activity in Psoriasis
Medicina (Kaunas). 2022 Jun 16;58(6):813. doi: 10.3390/medicina58060813.ABSTRACTPsoriasis is a complex immune-mediated inflammatory disorder that generates enormous interest within the scientific communities worldwide, with new therapeutic targets being constantly identified and tested. Despite the numerous topical and systemic medications available for the treatment of psoriasis, alternative therapies are still needed for the optimal management of some patients who present with localized, resistant lesions. Novel insights into the contribution of cutaneous neurogenic inflammation in the pathogenesis of psoriasis have yiel...
Source: Medicina (Kaunas) - June 24, 2022 Category: Universities & Medical Training Authors: Marius Nicolae Popescu Cristina Beiu M ădălina Gabriela Iliescu Mara M ădălina Mihai Liliana Gabriela Popa Ana Maria Alexandra St ănescu Mihai Berteanu Source Type: research
Po-01-167 efficacy of botulinum toxin type a (agn-151607) for the prevention of postoperative atrial fibrillation in cardiac surgery patients: atrial fibrillation and anticoagulation results from the phase 2 nova study
Oral anticoagulation reduces the risk of stroke but also increases the risk of bleeding. Prevention of post-operative atrial fibrillation (POAF) could result in a lower burden of oral anticoagulation and bleeding events. AGN-151607 has been proposed to prevent POAF and its safety/efficacy was tested in a multicenter randomized trial.
Source: Heart Rhythm - May 1, 2023 Category: Cardiology Authors: Nathan Waldron, Alexandra OSullivan, Jonathan P. Piccini, Matthew Romano, Pierre Voisine, Wilson Titanji, Richard Leaback, William Ferguson, Jonathan S. Steinberg Source Type: research
